A middle-market private equity firm identified uneven go-to-market performance across its portfolio. While individual management teams reported healthy pipeline and activity metrics, revenue outcomes varied significantly by company and were difficult to diagnose at the portfolio level.
The firm lacked a standardized way to:
- Assess true drivers of growth across portfolio companies
- Isolate performance gaps in pricing, mix, channel effectiveness, and sales execution
- Produce defensible, board-ready explanations for revenue variance
- Increase buyer confidence at exit through transparent performance visibility
Without a unified analytical framework, operating partners were reliant on management-reported dashboards that described results but did not decompose cause and effect. This limited the firm’s ability to accelerate growth during the hold period and constrained how credibly the story could be told in diligence.